- Home
- XNCR vs NBB Comparison
XNCR vs NBB Comparison
Compare XNCR & NBB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XNCR
- NBB
- Stock Information
- Founded
- XNCR 1997
- NBB 2009
- Country
- XNCR United States
- NBB United States
- Employees
- XNCR N/A
- NBB N/A
- Industry
- XNCR Biotechnology: Pharmaceutical Preparations
- NBB Finance Companies
- Sector
- XNCR Health Care
- NBB Finance
- Exchange
- XNCR Nasdaq
- NBB Nasdaq
- Market Cap
- XNCR 565.1M
- NBB 462.1M
- IPO Year
- XNCR 2013
- NBB N/A
- Fundamental
- Price
- XNCR $8.44
- NBB $15.51
- Analyst Decision
- XNCR Buy
- NBB
- Analyst Count
- XNCR 7
- NBB 0
- Target Price
- XNCR $27.50
- NBB N/A
- AVG Volume (30 Days)
- XNCR 777.2K
- NBB 73.9K
- Earning Date
- XNCR 08-04-2025
- NBB 01-01-0001
- Dividend Yield
- XNCR N/A
- NBB 8.64%
- EPS Growth
- XNCR N/A
- NBB N/A
- EPS
- XNCR N/A
- NBB N/A
- Revenue
- XNCR $127,228,000.00
- NBB N/A
- Revenue This Year
- XNCR N/A
- NBB N/A
- Revenue Next Year
- XNCR $28.84
- NBB N/A
- P/E Ratio
- XNCR N/A
- NBB N/A
- Revenue Growth
- XNCR N/A
- NBB N/A
- 52 Week Low
- XNCR $7.16
- NBB $13.67
- 52 Week High
- XNCR $27.24
- NBB $16.66
- Technical
- Relative Strength Index (RSI)
- XNCR 47.36
- NBB 49.37
- Support Level
- XNCR $7.93
- NBB $15.62
- Resistance Level
- XNCR $9.48
- NBB $15.91
- Average True Range (ATR)
- XNCR 0.53
- NBB 0.19
- MACD
- XNCR 0.06
- NBB -0.02
- Stochastic Oscillator
- XNCR 43.29
- NBB 41.67
About XNCR Xencor Inc.
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.
About NBB Nuveen Taxable Municipal Income Fund of Beneficial Interest
Nuveen Taxable Municipal Income Fund is a closed-end fund incorporated in the United States. Its primary objective is current income through investments in taxable municipal securities; the secondary objective is to seek enhanced portfolio value and total return. The fund invests primarily in a diversified portfolio of taxable municipal securities.